These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28179414)

  • 1. Comparison of the therapeutic dose of warfarin in HIV-infected and HIV-uninfected patients: a study of clinical practice.
    Jackson BS; Mokoena T
    BMJ Open; 2017 Feb; 7(2):e013709. PubMed ID: 28179414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
    Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW; Eriksson H; Lundström T; Berkowitz SD; Nyström P; Thorsén M; Ginsberg JS;
    JAMA; 2005 Feb; 293(6):681-9. PubMed ID: 15701909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous Thromboembolism Requiring Extended Anticoagulation Among HIV-Infected Patients in a Rural, Resource-Constrained Setting in Western Kenya.
    Kanyi J; Karwa R; Pastakia SD; Manji I; Manyara S; Saina C
    Ann Pharmacother; 2017 May; 51(5):380-387. PubMed ID: 28056524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin induction at 5 mg daily is safe with a low risk of anticoagulant overdose: results of an audit of patients with deep vein thrombosis commencing warfarin.
    Harper P; Monahan K; Baker B
    Intern Med J; 2005 Dec; 35(12):717-20. PubMed ID: 16313547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin therapy in the HIV medical home model: low rates of therapeutic anticoagulation despite adherence and differences in dosing based on specific antiretrovirals.
    Anderson AM; Chane T; Patel M; Chen S; Xue W; Easley KA
    AIDS Patient Care STDS; 2012 Aug; 26(8):454-62. PubMed ID: 22742455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes.
    Deitelzweig SB; Lin J; Kreilick C; Hussein M; Battleman D
    Adv Ther; 2010 Sep; 27(9):623-33. PubMed ID: 20680533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of warfarin and low range INR in the prevention of recurrent venous thrombosis].
    Quintero J; Torres E; Diez-Ewald M; Arteaga-Vizcaíno M; Vizcaíno G; León M; Rodríguez Z; Fernández N
    Invest Clin; 2011 Sep; 52(3):230-8. PubMed ID: 21950194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A probable interaction between warfarin and the antiretroviral TRIO study regimen.
    Liedtke MD; Vanguri A; Rathbun RC
    Ann Pharmacother; 2012 Nov; 46(11):e34. PubMed ID: 23115227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHALLENGES IN MANAGEMENT OF WARFARIN ANTI-COAGULATION IN ADVANCED HIV/AIDS PATIENTS WITH VENOUS THROMBOTIC EVENTS--A CASE SERIES FROM A RESEARCH CLINIC IN RURAL KERICHO, KENYA.
    Tarus NK; Pau AK; Sereti I; Kirui FK; Sawe FK; Agan BK; Momanyi LM; Ngeno HC; Koskei GK; Shaffer DN
    East Afr Med J; 2013 Jul; 90(7):207-13. PubMed ID: 26862618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal Starting Dose of Warfarin for Treatment of Deep Vein Thrombosis in Nepalese Context, A Retrospective- Prospective Institutional Review.
    Shrestha BK; Karmacharya RM; Devbhandari M; Tuladhar SM
    Kathmandu Univ Med J (KUMJ); 2017 Jul-Sept.; 15(59):249-252. PubMed ID: 30353902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
    Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
    J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of deep vein thrombosis with oral anticoagulants in patients with malignancy: prospective cohort study.
    Vucić N; Ostojić R; Svircić T
    Croat Med J; 2002 Jun; 43(3):296-300. PubMed ID: 12035135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism among HIV-positive patients and anticoagulation clinic outcomes integrated within the HIV primary care setting.
    Modi RA; McGwin G; Westfall AO; Powell DW; Burkholder GA; Raper JL; Willig JH
    Int J STD AIDS; 2015 Oct; 26(12):870-8. PubMed ID: 25414089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy and safety of acenocoumarol and warfarin therapy in patients with lower limb deep vein thrombosis].
    Bernát SI; Rókusz L
    Orv Hetil; 2012 May; 153(20):786-90. PubMed ID: 22580505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin Dosing and Time Required to Reach Therapeutic International Normalized Ratio in Patients with Hypercoagulable Conditions.
    Kahlon P; Nabi S; Arshad A; Jabbar A; Haythem A
    Turk J Haematol; 2016 Dec; 33(4):299-303. PubMed ID: 27093959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
    Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
    Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications].
    Vorob'eva NM; Panchenko EP; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Khasanova ZB; Postnov AIu; Kirienko AI
    Ter Arkh; 2011; 83(12):43-8. PubMed ID: 22416444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.